Fresenius Renal Therapies Introduces CLiC Device

Fresenius Renal Therapies has unveiled its CLiC device, the latest addition to its Crit-Line technology line, to address fluid management in patients with end-stage renal disease.

The device is designed to measure hematocrit, oxygen saturation and percent change in intravascular blood volume during hemodialysis. 

CLiC also provides direct access to a patient’s hematocrit in real-time, as well as the percent change in blood volume and oxygen saturation data, the company says. — Anisa Jibrell